These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34326654)

  • 61. Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson's disease.
    Lecours C; St-Pierre MK; Picard K; Bordeleau M; Bourque M; Awogbindin IO; Benadjal A; Ibanez FG; Gagnon D; Cantin L; Parent M; Di Paolo T; Tremblay ME
    Brain Behav Immun; 2020 Nov; 90():81-96. PubMed ID: 32755645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
    Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
    Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.
    Cao H; Han X; Jia Y; Zhang B
    Aging (Albany NY); 2021 Apr; 13(8):11455-11469. PubMed ID: 33839699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis.
    Zhang SZ; Wang QQ; Yang QQ; Gu HY; Yin YQ; Li YD; Hou JC; Chen R; Sun QQ; Sun YF; Hu G; Zhou JW
    BMC Med; 2019 Nov; 17(1):204. PubMed ID: 31727112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process.
    Yang X; Lou Y; Liu G; Wang X; Qian Y; Ding J; Chen S; Xiao Q
    J Neuroinflammation; 2017 Feb; 14(1):38. PubMed ID: 28219441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bushen-Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease.
    Mo Y; Xu E; Wei R; Le B; Song L; Li D; Chen Y; Ji X; Fang S; Shen J; Yang C; Wang Q
    Evid Based Complement Alternat Med; 2018; 2018():3571604. PubMed ID: 30224927
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NLRP3 mediates the neuroprotective effects of SVHRSP derived from scorpion venom in rotenone-induced experimental Parkinson's disease model.
    Zhang Y; Li S; Hou L; Wu M; Liu J; Wang R; Wang Q; Zhao J
    J Ethnopharmacol; 2023 Aug; 312():116497. PubMed ID: 37072089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.
    Chung YC; Bok E; Huh SH; Park JY; Yoon SH; Kim SR; Kim YS; Maeng S; Park SH; Jin BK
    J Immunol; 2011 Dec; 187(12):6508-17. PubMed ID: 22079984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease.
    Gan P; Ding L; Hang G; Xia Q; Huang Z; Ye X; Qian X
    Front Pharmacol; 2020; 11():776. PubMed ID: 32528295
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease.
    Guan J; Yang B; Fan Y; Zhang J
    Neuroimmunomodulation; 2017; 24(1):60-66. PubMed ID: 28810246
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
    Zhang G; Yang G; Liu J
    Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone marrow mesenchymal stem cells upregulate PI3K/AKT pathway and down-regulate NF-κB pathway by secreting glial cell-derived neurotrophic factors to regulate microglial polarization and alleviate deafferentation pain in rats.
    Zhong Z; Chen A; Fa Z; Ding Z; Xiao L; Wu G; Wang Q; Zhang R
    Neurobiol Dis; 2020 Sep; 143():104945. PubMed ID: 32428552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinson's disease.
    Zhang X; Tu D; Li S; Li N; Li D; Gao Y; Tian L; Liu J; Zhang X; Hong JS; Hou L; Zhao J; Wang Q
    Free Radic Biol Med; 2022 Aug; 188():363-374. PubMed ID: 35760232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-κB signalling pathway in Parkinson's disease model.
    Gan P; Xia Q; Hang G; Zhou Y; Qian X; Wang X; Ding L
    Clin Exp Pharmacol Physiol; 2019 Apr; 46(4):337-349. PubMed ID: 30485484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.
    Kim KI; Chung YC; Jin BK
    Mediators Inflamm; 2018; 2018():4591289. PubMed ID: 30692871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice.
    Yao K; Zhao YF
    Exp Gerontol; 2018 Oct; 111():86-93. PubMed ID: 30009921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.